Cutler Group LP Phathom Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$6.21 - $11.05 $7,452 - $13,260	-1,200 Reduced 48.0%	1,300 $3,000
Q4 2023 Jan 18, 2024	BUY	$6.99 - $10.71 $17,475 - $26,775	2,500 New	2,500 $4,000
Q1 2023 May 01, 2023	BUY	$6.19 - $12.36 $12,380 - $24,720	2,000 New	2,000 $1,000
Q3 2021 Oct 26, 2021	BUY	$30.69 - $36.83 $9,207 - $11,049	300 New	300 $0

144

73.6M

42.3K

45.7K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $294M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.